Sangamo BioSciences, Inc. misses by $0.03, beats on revenue

Sangamo BioSciences, Inc. (SGMO): Q4 EPS of -$0.13 misses by $0.03.

Revenue of $6.9M (-22.7% Y/Y) beats by $1.21M.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs